New Delhi (PTI): The manufacturer of Coldrif syrup, whose consumption is alleged to have killed at least 20 children in Madhya Pradesh, used industrial-grade raw materials instead of pharma-grade sans quality checks to prepare the medicine, an ED probe has found.

The federal probe agency further claimed that officials of the Tamil Nadu Drugs Control Department were in "frequent touch" with proprietor G Ranganathan of the accused company-- Chennai-based Sresan Pharmaceuticals-- but the mandated annual inspections of the firm were "not" conducted.

The Enforcement Directorate said this in a statement issued on Wednesday as it attached two flats in Chennai belonging to Ranganathan and his family members.

The assets are located at Kodambakkam in Tamil Nadu's capital city and are worth Rs 2.04 crore, the statement said.

Ranganathan was arrested by the Madhya Pradesh Police in October.

The agency alleged Sresan Pharma indulged in "rampant unfair trade practices to suppress its manufacturing costs and increase profits which are nothing but proceeds of crime under the Prevention of Money Laundering Act".

Probe found, it said, that the manufacturer used industry-grade raw materials in the manufacturing of medicines instead of pharma-grade raw materials "without" proper quality checks.

"Such materials were being purchased in cash without invoices to avoid creation of records," the ED said.

Though the officials of the Tamil Nadu Drugs Control Department were in frequent touch with the proprietor of Sresan Pharma, the annual inspections mandated as per the Drug and Cosmetic Rules were "not" conducted, it added.

The ED booked a money laundering case against the accused taking cognisance of two FIRs, one filed by the Madhya Pradesh Police and other by the Tamil Nadu Police.

The Madhya Pradesh Police complaint alleged that Coldrif contained toxic glycol compounds and caused multiple incidents of acute renal failure in children leading to the death of at least 20 children in the state.

Laboratory findings confirmed the presence of "high" concentrations of Diethylene Glycol (DEG) and Ethylene Glycol (EG), far beyond the safe limit, according to the police FIR.

"The negligent and adulterated manufacturing practices adopted by Sresan Pharma led to the poisoning of the cough syrup," the ED said quoting the police FIR.

The second complaint which the ED took cognisance of was filed by the Tamil Nadu Directorate of Vigilance and Anti-Corruption (DVAC) against P U Karthikeyan, director in-charge of the Tamil Nadu Food Safety and Drug Administration Department in an alleged bribery case. Karthikeyan was arrested by the DVAC in July.

Tamil Nadu ordered the closure of the accused pharma company after the deaths and also suspended two drug inspectors.

Madhya Pradesh also suspended two drug inspectors apart from a Food and Drug Administration deputy director.

Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.



New Delhi (PTI): Russia agreed to encourage joint manufacturing in India of military hardware and spare parts for maintenance of Russian-origin arms and defence equipment.

Ways to bolster overall bilateral defence cooperation figured prominently during summit talks between Prime Minister Narendra Modi and Russian President Vladimir Putin on Friday.

It has been a long-standing grievance of armed forces that the supply of critical spares and equipment from Russia takes a long time, affecting the maintenance of military systems procured from that country.

"Both sides agreed to encourage joint manufacturing in India of spare parts, components, aggregates and other products for maintenance of Russian origin arms and defence equipment under Make-in-India programme through transfer of technology," a joint statement said.

ALSO READ: India, Russia explore cooperation on small modular reactors, floating nuclear power plants

It said both sides also agreed to set up joint ventures for meeting the needs of the Indian armed forces as well as subsequent export to mutually friendly third countries.

The joint statement said the India-Russia defence partnership is being reoriented to take up joint co-development and co-production of advanced defence technology and systems.

In their meeting on Thursday, Defence Minister Rajnath Singh and his Russian counterpart Andrey Belousov resolved to expand bilateral defence cooperation.

In the meeting, the Indian side showed keen interest in procurement of additional batches of S-400 missile systems from Moscow to bolster its combat prowess.

In October 2018, India signed a USD 5 billion deal with Russia to buy five units of the S-400 air defence missile systems, notwithstanding a warning by the US that going ahead with the contract may invite US sanctions under the provisions of Countering America's Adversaries Through Sanctions Act (CAATSA).

Three squadrons have already been delivered.

The S-400 systems played a crucial role during Operation Sindoor. India may also look at procuring the S-500 missile systems from Russia.

In the Modi-Putin talks, the two sides also agreed to continue jointly developing systems of bilateral trade settlements through the use of national currencies.

Additionally, the two sides agreed to continue their consultations on enabling the interoperability of the national payment systems, financial messaging systems, as well as central bank digital currency platforms.

Modi and Putin appreciated the ongoing intensification of the joint work on a free trade agreement on goods between India and the Eurasian Economic Union, covering sectors of mutual interest, the joint statement said.

They also directed both sides to intensify efforts in negotiations on a mutually beneficial agreement on the promotion and protection of investment, it said.

India and Russia also welcomed steps to ensure long-term supply of fertilisers to India and discussed the potential establishment of joint ventures in this area.